Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Xu, Yu ^a   Li, Peizhong ^a   Zhang, Xin ^a   Wang, Junying ^a   Gu, Dongsheng ^a   Wang, Yao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Expression; Immunohistochemistry; Nasopharyngeal carcinoma; Neuropilin 1; Prognosis

Indexed keywords

NEUROPILIN 1; PARAFFIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CANCER STAGING; CHEMISTRY; CHI SQUARE DISTRIBUTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TUMOR RECURRENCE; UPREGULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROPILIN-1; PARAFFIN EMBEDDING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84884884145     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-155     Document Type: Article

References (27)

1. Glastonbury CM, Salzman KL. Pitfalls in the staging of cancer of nasopharyngeal carcinoma. Neuroimaging Clin N Am 2013, 23:9-25. 10.1016/j.nic.2012.08.006, 23199659.
2. Han BL, Xu XY, Zhang CZ, Wu JJ, Han CF, Wang H, Wang X, Wang GS, Yang SJ, Xie Y. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev 2012, 13:2577-2581. 10.7314/APJCP.2012.13.6.2577, 22938423.
3. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012, 22:233-244. 10.1016/j.semradonc.2012.03.008, 22687948.
4. Hughes J, Alusi G, Wang Y. Gene therapy and nasopharyngeal carcinoma. Rhinology 2012, 50:115-121.
5. Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer 2012, 12:98. 10.1186/1471-2407-12-98, 3353248, 22433671.
6. Mao Y, Zhang DW, Zhu H, Lin H, Xiong L, Cao Q, Liu Y, Li QD, Xu JR, Xu LF, Chen RJ. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL). Diagn Pathol 2012, 7:178. 10.1186/1746-1596-7-178, 3539909, 23237707.
7. Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J 2008, 411:211-226. 10.1042/BJ20071639, 18363553.
8. Geretti E, Shimizu A, Klagsbrun M. Neuropilin structure governs VEGF and semaphorin binding and regulates angio-genesis. Angiogenesis 2008, 11:31-39. 10.1007/s10456-008-9097-1, 18283547.
9. Grünewald FS, Prota AE, Giese A, Ballmer-Hofer K. Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim Biophys Acta 1804, 2010:567-580.
10. Chen L, Miao W, Tang X, Zhang H, Wang S, Luo F, Yan J. The expression and significance of neuropilin-1 (NRP-1) on glioma cell lines and glioma tissues. J Biomed Nanotechnol 2013, 9:559-563. 10.1166/jbn.2013.1624, 23621014.
11. Pallaoro A, Braun GB, Moskovits M. Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression. Proc Natl Acad Sci U S A 2011, 108:16559-16564. 10.1073/pnas.1109490108, 3189017, 21930955.
12. Jubb AM, Strickland LA, Liu SD, Mak J, Schmidt M, Koeppen H. Neuropilin-1 expression in cancer and development. J Pathol 2012, 226:50-60. 10.1002/path.2989, 22025255.
13. Akagi M, Kawaguchi M, Liu W, McCarty MF, Takeda A, Fan F, Stoeltzing O, Parikh AA, Jung YD, Bucana CD, Mansfield PF, Hicklin DJ, Ellis LM. Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Br J Cancer 2003, 88:796-802. 10.1038/sj.bjc.6600811, 2376351, 12618892.
14. Parikh AA, Liu WB, Fan F, Stoeltzing O, Reinmuth N, Bruns CJ, Bucana CD, Evans DB, Ellis LM. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer 2003, 98:720-729. 10.1002/cncr.11560, 12910515.
15. Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N, Bielenberg D, Bucana CD, Klagsbrun M, Ellis LM. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 2004, 164:2139-2151. 10.1016/S0002-9440(10)63772-8, 1615754, 15161648.
16. Kreuter M, Woelke K, Bieker R, Schliemann C, Steins M, Buechner T, Berdel WE, Mesters RM. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia 2006, 20:1950-1954. 10.1038/sj.leu.2404384, 16990775.
17. de Paulis A, Prevete N, Fiorentino I, Rossi FW, Staibano S, Montuori N, Ragno P, Longobardi A, Liccardo B, Genovese A, Ribatti D, Walls AF, Marone G. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol 2006, 177:7322-7331.
18. Ellis LM. The role of neuropilins in cancer. Mol Cancer Ther 2006, 5:1099-1107. 10.1158/1535-7163.MCT-05-0538, 16731741.
19. Latil A, Bieche I, Pesche S, Valeri A, Fournier G, Cussenot O, Lidereau R. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 2000, 89:167-171. 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9, 10754495.
20. Madri JA. Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 2009, 60:95-104.
21. Meyerson HJ, Blidaru G, Edinger A, Osei E, Schweitzer K, Fu P, Ho L. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia. Am J Clin Pathol 2012, 137:39-50. 10.1309/AJCP6VDBL4BRXRQA, 22180477.
22. Li X, Tang T, Lu X, Zhou H, Huang Y. RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis. Mol Med Rep 2011, 4:1261-1266.
23. Xu J, Xia J. NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo. Exp Ther Med 2013, 5:150-154. 3524282, 23251257.
24. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 2004, 28:347-356. 10.1097/00000478-200403000-00007, 15104297.
25. Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K, Fujii S. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol 2007, 105:703-711. 10.1016/j.ygyno.2007.02.005, 17376520.
26. Stephenson JM, Banerjee S, Saxena NK, Cherian R, Banerjee SK. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int J Cancer 2002, 101:409-414. 10.1002/ijc.10611, 12216067.
27. Kamiya T, Kawakami T, Abe Y, Nishi M, Onoda N, Miyazaki N, Oida Y, Yamazaki H, Ueyama Y, Nakamura M. The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer. Oncol Rep 2006, 15:369-373.